Short Communication
Prevalence of High-Burden Medical Conditions Among Young and Middle-Aged Adults With Pediatric-Onset Medical Conditions: Findings From US Private and Public Administrative Claims Data
Daniel G. Whitney * 
Cited by CrossRef:
1- Whitney D, Schmidt M, Bell S, Morgenstern H, Hirth R. Incidence Rate of Advanced Chronic Kidney Disease Among Privately Insured Adults with Neurodevelopmental Disabilities
. CLEP. 2020;Volume 12:235 [Crossref]
2- Whitney D, Hurvitz E, Caird M. Critical periods of bone health across the lifespan for individuals with cerebral palsy: Informing clinical guidelines for fracture prevention and monitoring. Bone. 2021;150:116009 [Crossref]
3- Whitney D, Bell S, Whibley D, Van der Slot W, Hurvitz E, Haapala H, Peterson M, Warschausky S. Effect of pain on mood affective disorders in adults with cerebral palsy. Develop Med Child Neuro. 2020;62(8):926 [Crossref]
4- Sattoe J, Hilberink S. Impairments and comorbidities in adults with cerebral palsy and spina bifida: a meta-analysis. Front Neurol. 2023;14 [Crossref]
5- Whitney D, Bell S, Etter J, Prisby R. The cardiovascular disease burden of non-traumatic fractures for adults with and without cerebral palsy. Bone. 2020;136:115376 [Crossref]
6- French Z, Caird M, Whitney D. Osteoporosis Epidemiology Among Adults With Cerebral Palsy: Findings From Private and Public Administrative Claims Data. JBMR Plus. 2019;3(11) [Crossref]
7- McNeish B, Richardson J, Bell S, Whitney D. Chemotherapy‐induced peripheral neuropathy increases nontraumatic fracture risk in breast cancer survivors. JBMR Plus. 2021;5(8) [Crossref]
8- Whitney D, Oliverio A, Kamdar N, Viglianti B, Naik A, Schmidt M. Advanced CKD Among Adults With Cerebral Palsy: Incidence and Risk Factors. Kidney Medicine. 2020;2(5):569 [Crossref]
9- Whitney D, Schmidt M, Haapala H, Ryan D, Hurvitz E, Peterson M. Timecourse of Morbidity Onset Among Adults Living With Cerebral Palsy. American Journal of Preventive Medicine. 2021;61(1):37 [Crossref]
10- Whitney D, Bell S, Hurvitz E, Peterson M, Caird M, Jepsen K. The mortality burden of non-trauma fracture for adults with cerebral palsy. Bone Reports. 2020;13:100725 [Crossref]
11- Whitney D, Schmidt M, Haapala H. Polypharmacy is a risk factor for mortality, severe chronic kidney disease, and liver disease among privately insured adults with cerebral palsy. JMCP. 2021;27(1):51 [Crossref]
12- Whitney D, Caird M, Jepsen K, Hurvitz E, Hirth R. Excess healthcare spending associated with fractures among adults with cerebral palsy. Disability and Health Journal. 2022;15(3):101315 [Crossref]
13- Whitney D, Schmidt M, Peterson M, Haapala H. Polypharmacy Among Privately Insured Adults with Cerebral Palsy: A Retrospective Cohort Study. JMCP. 2020;26(9):1153 [Crossref]
14- Whitney D, Whibley D, Jepsen K. The effect of low-trauma fracture on one-year mortality rate among privately insured adults with and without neurodevelopmental disabilities. Bone. 2019;129:115060 [Crossref]
15- Whitney D, Bell S, McNamara N, Hurvitz E. The mortality burden attributable to nontrauma fracture for privately insured adults with epilepsy. Epilepsia. 2020;61(4):714 [Crossref]
16- Whitney D, Hurvitz E, Caird M. The Effect of Osteoporosis Medication on Risk Attenuation of Non-Trauma Fracture Among Adults with Cerebral Palsy: A Propensity Score-Matched Observational Study. CLEP. 2021;Volume 13:91 [Crossref]
17- Whitney D, Kamdar N. Development of a new comorbidity index for adults with cerebral palsy and comparative assessment with common comorbidity indices. Develop Med Child Neuro. 2021;63(3):313 [Crossref]
18- Whitney D, Pruente J, Schmidt M. Risk of advanced chronic kidney disease among adults with spina bifida. Annals of Epidemiology. 2020;43:71 [Crossref]
19- Whitney D, Basu T. Whitney Comorbidity Index to monitor health status for adults with cerebral palsy: validation and thresholds to assist clinical decision making. Develop Med Child Neuro. 2021;63(7):853 [Crossref]
20- Leis A, Hurvitz E, Whitney D. Comorbidity Clusters Among Adults With Cerebral Palsy: A Latent Class Analysis. American Journal of Preventive Medicine. 2024;66(6):971 [Crossref]